U.S. Air Force to provide free home testing kits for fertility through MFB contract

July 17, 2020
Digital Transformation More...
Average importance

Fertility testing is often done in doctors' offices, but it is increasingly possible to move the provision of this kind of care into the home with mail-in testing services. Home testing has been gaining popularity for years but is being accelerated by COVID-19, where there is a need to outsource as many medical services into the home as reasonably possible. Fertility testing in particular is a powerful use case because it affords privacy to the consumer, and the U.S. Air Force's choice to provide this service is a potent testament to its use case. Telehealth is being hyped right now due to COVID-19, but clients should be looking to the less stereotypical modes of telehealth like remote monitoring (including home testing) for lasting ROIs.

For the original news article, click here .

Further Reading

Apple to develop digital biomarkers for detection of flu and heart failure

News Commentary | November 10, 2020

Apple trails behind other wearables like Fitbit and Oura in terms of infection detection capabilities, but it has been deepening its presence in cardiac conditions (although it needs to improve its atrial fibrillation detection algorithms). This development is important, as the development of ... Not part of subscription

FDA authorizes emergency use of Lucira's at-home test kit – with results in 30 minutes and no shipping to a lab

News Commentary | November 25, 2020

This advancement in POC testing is one that decentralizes the testing process and allows for nearly immediate self‑quarantine and thereby reducing the burden on shipping and laboratory infrastructure. While clients may want to take note of this development for use for their own employees, clients ... To read more, click here.

Helix's pivot from consumer genomics to population genomics highlights broader shifts in the human genomics landscape

Case Study | July 29, 2021

Helix Genomics came into the spotlight a few years ago when it pioneered a digital marketplace concept for genomics where it used a dynamic consent model to allow third‑party developers to turn genomics data into personalized insights for the consumer. It also offered whole‑exome sequencing (WES), ... Not part of subscription